<SEC-DOCUMENT>0001628280-19-014834-index.html : 20191206
<SEC-HEADER>0001628280-19-014834.hdr.sgml : 20191206
<ACCEPTANCE-DATETIME>20191206171742
ACCESSION NUMBER:		0001628280-19-014834
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20191206
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20191206
DATE AS OF CHANGE:		20191206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		191273821

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8kreditrexapproval12-6x19.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a8kreditrexapproval12-6x19.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>methotrexateapprovalfinal.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: methotrexateapprovalfinal.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>methotrexateapprovalf_image1.jpg
<TEXT>
Document 3 - file: methotrexateapprovalf_image1.jpg

</DOCUMENT>
</SEC-DOCUMENT>